Systemic Markers of Interferon-γ–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease
- 1 March 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (3), 698-704
- https://doi.org/10.1161/atvbaha.110.219329
Abstract
Objective—: Interferon γ (IFN-γ) is centrally involved in atherosclerosis-related inflammation, but its activity cannot be reliably assessed by systemic measurements. In activated macrophages, IFN-γ stimulates production of neopterin and conversion of tryptophan to kynurenine. We evaluated the relationships of plasma neopterin and plasma kyunernine:tryptophan ratio (KTR) to long-term prognosis in patients with stable angina pectoris and angiographically verified significant coronary artery disease. Methods and Results—: Samples were obtained from 2380 patients with a mean age of 63.7 years; 77.3% were men. During a median follow-up of 56 months, 10.8% of patients experienced a major coronary event (MCE), and 9.5% died. For MCE, each SD increment of neopterin and KTR (logarithmically transformed) was associated with multivariable adjusted hazard ratios and 95% CIs of 1.28 (1.10 to 1.48) and 1.28 (1.12 to 1.48), respectively. The corresponding hazard ratios (95% CIs) for all-cause mortality were 1.40 (1.21 to 1.62) (neopterin) and 1.23 (1.06 to 1.43) (KTR). Conclusion—: In patients with stable angina pectoris, systemic markers of IFN-γ activity, plasma neopterin, and plasma KTR provide similar risk estimates for MCE and mortality. Our results support experimental data linking IFN-γ to acute atherosclerotic complications.Keywords
This publication has 35 references indexed in Scilit:
- The role of neopterin in atherogenesis and cardiovascular risk assessment.Current Medicinal Chemistry, 2009
- Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health StudyClinical Chemistry, 2009
- Interferon gamma: A master regulator of atherosclerosisCytokine & Growth Factor Reviews, 2009
- Genetically Elevated C-Reactive Protein and Ischemic Vascular DiseaseThe New England Journal of Medicine, 2008
- Long-Term Prognostic Value of NeopterinCirculation, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectorisEuropean Heart Journal, 2005
- Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery diseaseThe American Journal of Cardiology, 2004
- Inflammation and atherosclerosis: role of C-Reactive protein in risk assessmentThe American Journal of Medicine, 2004
- Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crimeNature Medicine, 2002